Envestnet Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $25.5M | Buy |
126,996
+12,339
| +11% | +$2.55M | 0.01% | 1184 |
|
|
2025
Q4 | $23.7M | Sell |
114,657
-6,266
| -5% | -$1.25M | 0.01% | 1109 |
|
|
2025
Q3 | $21.7M | Buy |
120,923
+438
| +0.4% | +$74.6K | 0.01% | 1226 |
|
|
2025
Q2 | $19.4M | Buy |
120,485
+4,945
| +4% | +$788K | 0.01% | 1275 |
|
|
2025
Q1 | $19.7M | Buy |
115,540
+1,985
| +2% | +$345K | 0.01% | 1204 |
|
|
2024
Q4 | $18.9M | Buy |
113,555
+4,878
| +4% | +$834K | 0.01% | 1235 |
|
|
2024
Q3 | $18.7M | Buy |
108,677
+58,585
| +117% | +$9.7M | 0.01% | 1223 |
|
|
2024
Q2 | $7.71M | Sell |
50,092
-1,426
| -3% | -$214K | ﹤0.01% | 1726 |
|
|
2024
Q1 | $7.92M | Sell |
51,518
-3,162
| -6% | -$482K | ﹤0.01% | 1677 |
|
|
2023
Q4 | $8.64M | Buy |
54,680
+13,354
| +32% | +$1.92M | ﹤0.01% | 1537 |
|
|
2023
Q3 | $6.05M | Sell |
41,326
-5,122
| -11% | -$780K | ﹤0.01% | 1676 |
|
|
2023
Q2 | $7.11M | Buy |
46,448
+3,610
| +8% | +$563K | ﹤0.01% | 1499 |
|
|
2023
Q1 | $6.64M | Sell |
42,838
-6,637
| -13% | -$1.04M | ﹤0.01% | 1499 |
|
|
2022
Q4 | $7.63M | Buy |
49,475
+2,947
| +6% | +$435K | ﹤0.01% | 1346 |
|
|
2022
Q3 | $6.14M | Buy |
46,528
+2,015
| +5% | +$283K | ﹤0.01% | 1415 |
|
|
2022
Q2 | $6.03M | Sell |
44,513
-3,034
| -6% | -$418K | ﹤0.01% | 1425 |
|
|
2022
Q1 | $7.09M | Sell |
47,547
-1,360
| -3% | -$201K | ﹤0.01% | 1408 |
|
|
2021
Q4 | $7.92M | Sell |
48,907
-11,061
| -18% | -$1.79M | ﹤0.01% | 1326 |
|
|
2021
Q3 | $9.96M | Sell |
59,968
-30,201
| -33% | -$5.16M | 0.01% | 1153 |
|
|
2021
Q2 | $15.6M | Sell |
90,169
-4,257
| -5% | -$703K | 0.01% | 901 |
|
|
2021
Q1 | $15.2M | Sell |
94,426
-20,083
| -18% | -$3.44M | 0.01% | 834 |
|
|
2020
Q4 | $19.2M | Sell |
114,509
-4,603
| -4% | -$747K | 0.01% | 631 |
|
|
2020
Q3 | $18.7M | Buy |
119,112
+6,255
| +6% | +$1.02M | 0.02% | 575 |
|
|
2020
Q2 | $18.9M | Buy |
112,857
+16,180
| +17% | +$2.54M | 0.02% | 543 |
|
|
2020
Q1 | $12.7M | Buy |
96,677
+17,901
| +23% | +$2.55M | 0.02% | 596 |
|
|
2019
Q4 | $11.7M | Buy |
78,776
+831
| +1% | +$114K | 0.01% | 738 |
|
|
2019
Q3 | $9.65M | Buy |
77,945
+1,445
| +2% | +$192K | 0.01% | 764 |
|
|
2019
Q2 | $10.8M | Buy |
76,500
+23,172
| +43% | +$3.2M | 0.01% | 696 |
|
|
2019
Q1 | $8.04M | Buy |
53,328
+8,595
| +19% | +$1.24M | 0.01% | 782 |
|
|
2018
Q4 | $5.56M | Buy |
44,733
+33,780
| +308% | +$4.62M | 0.01% | 837 |
|
|
2018
Q3 | $1.74M | Sell |
10,953
-10,983
| -50% | -$1.66M | ﹤0.01% | 632 |
|
|
2018
Q2 | $3.07M | Buy |
21,936
+1,774
| +9% | +$244K | 0.01% | 652 |
|
|
2018
Q1 | $2.66M | Buy |
20,162
+260
| +1% | +$35.5K | 0.01% | 608 |
|
|
2017
Q4 | $2.48M | Buy |
19,902
+230
| +1% | +$28.4K | 0.01% | 857 |
|
|
2017
Q3 | $2.44M | Sell |
19,672
-295
| -1% | -$34.9K | 0.01% | 817 |
|
|
2017
Q2 | $2.28M | Sell |
19,967
-4,467
| -18% | -$480K | 0.01% | 873 |
|
|
2017
Q1 | $2.57M | Sell |
24,434
-63
| -0.3% | -$6.31K | 0.01% | 829 |
|
|
2016
Q4 | $2.23M | Buy |
24,497
+13,999
| +133% | +$1.31M | 0.01% | 871 |
|
|
2016
Q3 | $1.05M | Sell |
10,498
-13,402
| -56% | -$1.31M | ﹤0.01% | 1230 |
|
|
2016
Q2 | $2.14M | Buy |
23,900
+104
| +0.4% | +$9.55K | 0.01% | 993 |
|
|
2016
Q1 | $2.08M | Sell |
23,796
-18,287
| -43% | -$1.61M | 0.01% | 969 |
|
|
2015
Q4 | $4.76M | Buy |
42,083
+3,150
| +8% | +$339K | 0.02% | 593 |
|
|
2015
Q3 | $3.94M | Buy |
38,933
+2,780
| +8% | +$331K | 0.02% | 655 |
|
|
2015
Q2 | $4.48M | Sell |
36,153
-5,234
| -13% | -$632K | 0.02% | 641 |
|
|
2015
Q1 | $4.89M | Buy |
41,387
+36,316
| +716% | +$4.11M | 0.03% | 573 |
|
|
2014
Q4 | $517K | Buy |
5,071
+4,883
| +2,597% | +$477K | 0.01% | 705 |
|
|
2014
Q3 | $17K | Sell |
188
-829
| -82% | -$71.9K | ﹤0.01% | 1941 |
|
|
2014
Q2 | $84K | Buy |
+1,017
| New | +$77.7K | ﹤0.01% | 1277 |
|
|
2013
Q3 | – | Sell |
-185
| Closed | -$11K | – | 2425 |
|
|
2013
Q2 | $11K | Buy |
+185
| New | +$10.6K | ﹤0.01% | 1625 |
|
Other funds holding FBT
BFG
NP
Envestnet Asset Management's FBT Position: Q1 2026 in Review
Envestnet Asset Management increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 11% in Q1 2026, buying an estimated $2.55M and bringing the position to 126,996 shares worth $25.5M. The position accounts for 0.01% of the portfolio, ranked #1184.
Envestnet Asset Management first reported a position in FBT in Q2 2013 and has held it in 49 quarters since. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.
- Envestnet Asset Management held 126,996 shares of First Trust NYSE Arca Biotechnology Index Fund worth $25.5M as of Q1 2026.
- Envestnet Asset Management bought 12,339 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $2.55M.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Envestnet Asset Management's portfolio in Q1 2026, its #1184 holding.
- Envestnet Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 49 quarters since.
- 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.
Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.